Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Dexmedetomidine for Non-invasive Ventilation After Chest Trauma (VENDETTA)

To see complete record on, please visit this link

Id: NCT02537366

Organisation Name: University Hospital, Grenoble

Overal Status: Completed

Start Date: September 2015

Last Update: March 9, 2017

Lead Sponsor: University Hospital, Grenoble

Brief Summary: Crossover randomized controlled double blinded trial :

The primary endpoint is the duration of Non Invasive Ventilation (NIV) session (minutes) with dexmedetomidine (DEX) or placebo.
Secondary endpoints will be the sedation level as assessed by the Richmond Agitation Sedation Scale (RASS), the number of interventions to allow the completion of NIV session, the pain intensity level as assessed by visual analogue scale, the morphine and ketamine consumption during NIV sessions, the comparison of blood gas measurements before and after NIV sessions, the reproducibility of NIV cycles. The side effects of DEX will be notified.

  • Thoracic Injuries

Total execution time in seconds: 0.25640296936035